Monday, October 24, 2011

Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book.

If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines


Get up-to-the-minute Globe Business Updates   |  More Business News
 
ADVERTISEMENT

Mon. Oct. 24, 2011

Mass. gas prices steady after uptick last week
The average price for gasoline in Massachusetts is unchanged this week after a one-cent uptick last week. AAA Southern New England says its latest weekly survey finds self-serve regular selling for an average of $3.42 per gallon. That’s 3 cents below the national average of $3.45. Last year at this time, self-serve regular was selling in Massachusetts for an average of $2.80.

Landmark High School will participate in Lemelson-MIT InvenTeam Initiative
A team of students, teachers, and mentors at Landmark High School in Beverly is one of 16 teams that will participate in the Lemelson-MIT Program’s 2011-2012 InvenTeam initiative. The Lemelson-MIT Program seeks to celebrate innovators and inspire young people to pursue careers through invention. For the initiative, the Landmark team aims to create desalinization units for villages in emerging nations. The team wants to develop a unit that can be fashioned from local recycled parts and that costs $50 or less.

Sanofi names Meeker as Genzyme division’s new chief executive
French drug maker Sanofi SA this morning

Vertex study will evaluate 12-week treatment period for some hepatitis C patients
Five months after it received regulatory approval for a potential blockbuster hepatitis C drug called Incivek, Vertex Pharmaceuticals Inc. is launching a study to evaluate whether some patients can be treated with a 12-week program rather than programs of 24 or 48 weeks. There is a subset of hepatitis C patients who tend to respond more quickly to treatment, and Cambridge-based Vertex is now evaluating whether a combination drug therapy for that group can be shortened.

Cubist to buy Adolor
Cubist Pharmaceuticals Inc. has agreed to buy all outstanding shares of Adolor Corp. with an up-front payment of $190 million. Adolor can qualify for additional payments if its drugs achieve regulatory and commercialization milestones; the total transaction is valued at up to $415 million, net of Adolor’s third quarter 2011 cash balance, Lexington-based Cubist said. Adolor of Pennsylvania markets a drug designed to accelerate recovery time for patients who have had bowel resection surgery, and it has another promising drug candidate in its pipeline.

Hebrew SeniorLife’s Chaplaincy Institute is cited for innovation
Hebrew SeniorLife’s Chaplaincy Institute has been named one of the nation’s 50 most innovative Jewish nonprofits. The list is compiled by Slingshot, which describes itself as a “resource guide to Jewish innovation.” In that capacity, it issues a “Zagat-style” guidebook to highlight the 50 most innovative nonprofits in North American Jewish life. Hebrew SeniorLife’s Chaplaincy Institute was included on this year’s list for its work in training chaplains in issues related to aging and improving the quality of Jewish pastoral care nationally. 

Pfizer to pay $14.5m to settle marketing charges
A federal prosecutor says the drugmaker Pfizer Inc. has agreed to pay the government $14.5 million to settle charges it illegally marketed its drug for a condition called an overactive bladder. The settlement resolves the last of 10 whistleblower lawsuits, dating back to 2003, that claimed Pfizer marketed a number of its drugs for unapproved uses. Pfizer agreed to pay $2.3 billion two years ago to settle both criminal charges and civil claims in many of those cases, and the rest were dismissed.

Rosa Mexicano and its upscale Mexican food are coming to the S. Boston waterfront
Rosa Mexicano, a high-end Mexican restaurant, will open a location at Seaport West on the South Boston waterfront, Seaport West’s owner said. The owner is Pembroke Real Estate, whose Seaport Place is home to about 5,000 office workers. When Rosa Mexicano opens next year on the corner of Seaport Boulevard and B Street, it will join several other restaurants at Seaport Place, including Morton’s the Steakhouse, Aura, and Tamo. Rosa Mexicano’s Boston restaurant will include an outdoor patio overlooking Boston Harbor.

Motion capture suit for rowers includes technology from Analog Devices
A new motion capture suit is now being used to explore ways to improve the performance of competitive rowers and reduce their injuries, and the motion capture suit incorporates some technology from Analog Devices Inc. The Norwood company is working on the rowers’ project with Roessingh Research & Development, a Dutch research center specializing in ambulatory 3D analysis of human motion. The center is using a system developed by Xsens Technologies B.V., also of the Netherlands, to study rowing kinematics.

Report: Apple, Android dominate the tablet computer market
The shipment of tablet computers worldwide reached nearly 17 million units in the third quarter, with Apple iOS and Android dominating the worldwide market with a combined 94 percent share, according to research from Strategy Analytics. In the third quarter, Microsoft captured a niche 2 percent global tablet share, said Strategy Analytics, a research and consulting firm headquartered in Boston. The firm’s conclusion? The future release of Windows 8 cannot come quickly enough for Microsoft.

Bain Capital agrees to buy large Japanese restaurant chain
Bain Capital, a Boston-based private investment firm that has invested in several restaurant chains including Dunkin’ Donuts, has agreed to buy Skylark Co. Ltd., a Japanese family restaurant chain, from Nomura Principal Finance Co. and other investors. The transaction has an equity value of about $2.1 billion. Skylark operates more than 3,600 outlets and has about $4.5 billion in annual revenues. Previous Bain Capital restaurant investments include Burger King, Dunkin’ Donuts parent company, and Domino’s Pizza.

No comments:

Post a Comment